Peptides for pelvic floor and vaginismus: what the evidence says

What did @borispil.la actually say?

Honestly, it's hard to tell. The transcript we have is garbled beyond any reasonable interpretation: "So leave a little special kinda neck Get it what they want and just stab you in the back nine times I've been to" reads like a transcription error or audio corruption, not a coherent health claim. The hashtags, though, tell a different story. This video is tagged under vaginismus dating, pelvic floor, and first time, which suggests the creator intended to discuss sexual health or pelvic floor dysfunction. The video was also categorized under peptide therapy. We're working with fragmented evidence here, so we'll assess what those hashtags and category imply rather than words that clearly didn't transcribe correctly.

Giving the creator the benefit of the doubt: they appear to be someone sharing personal experience with vaginismus, possibly alongside interest in peptide-based recovery. That's a real intersection worth examining.

Does the science back this up?

Pelvic floor dysfunction, including vaginismus, is well-documented and treatable. Peptide therapy as a recovery tool is a different, much murkier story. The evidence base varies wildly depending on the peptide in question.

Vaginismus, now more accurately classified under genito-pelvic pain or penetration disorder in the DSM-5, responds well to pelvic floor physical therapy, cognitive behavioral approaches, and graduated dilation. A 2014 meta-analysis by ter Kuile et al. in the Annual Review of Clinical Psychology confirmed that behavioral interventions show strong outcomes. That part is solid.

Where peptides enter this space is less clear. BPC-157 has shown connective tissue repair effects in animal studies, including work by Sikiric et al. (2018, Current Pharmaceutical Design), but human trials for pelvic floor applications simply do not exist yet. GHK-Cu has demonstrated anti-inflammatory properties in vitro, but applying that to pelvic pain or sexual health outcomes is a leap the current literature does not support.

What did they get wrong (or right)?

We can't fairly accuse the creator of making specific false claims when the transcript is unreadable. What we can say is this: the combination of vaginismus content and peptide therapy categorization raises a flag worth addressing.

If the creator implied that peptides like BPC-157 or TB-500 could treat vaginismus directly, that would be misleading. Vaginismus is primarily a neuromuscular and psychological condition. There is no peer-reviewed evidence that peptide therapy addresses the pelvic floor hypertonicity or the conditioned fear response driving it.

On the other hand, if the creator was simply sharing personal experience with pelvic floor work, and separately with peptide use for general recovery, that's two different conversations that often get blurred together on wellness-adjacent platforms. Personal experience content isn't inherently wrong. It's just not a treatment recommendation. The concern is when viewers in pain conflate a creator's anecdote with clinical guidance.

What should you actually know?

Vaginismus affects an estimated 1-7% of people with vaginas globally, though underreporting is significant. It is treatable, and most people who pursue structured pelvic floor therapy see meaningful improvement. The first stop should be a pelvic floor physical therapist, not a supplement stack.

Peptide therapies like BPC-157 and TB-500 are used off-label in optimization and recovery contexts. They are not FDA-approved treatments for any condition. Compounded peptides vary in quality and are not equivalent to any approved pharmaceutical product. If you are considering peptides for recovery purposes, that conversation belongs with a licensed provider who can review your full health picture, not a TikTok comment section.

The overlap between sexual health vulnerability and wellness product marketing is worth watching critically. People dealing with painful or difficult sexual health conditions are a target-rich environment for unproven solutions. Skepticism is not pessimism here. It is self-protection.